LIXTE BIOTECHNOLOGY HOLDINGS, INC. (NMAD) Shareholders’ equity 2010–2015
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (NMAD) shareholders’ equity at each fiscal year-end, per SEC filings.
$312,333FY2015 · since FY2010: $1.7M → $312,333
| Fiscal year | Value | YoY |
|---|---|---|
| FY2015 | $312,333 | — |
| FY2013 | $236,266 | -84.2% |
| FY2012 | $1.5M | +1787.9% |
| FY2011 | $79,021 | -95.4% |
| FY2010 | $1.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice